NCT05376969View on ClinicalTrials.gov

Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin

PHASE3CompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

May 25, 2021

Primary Completion Date

May 16, 2022

Study Completion Date

May 16, 2022

Conditions
T2DM (Type 2 Diabetes Mellitus)
Interventions
DRUG

DWP16001

DWP16001 Tablets

Trial Locations (1)

Unknown

Daewoong pharmatceutical, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT05376969 - Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin | Biotech Hunter | Biotech Hunter